Forecast & Rating4 analysts currently cover Annovis Bio, of which 4 give a positive rating. The average price target is $10.50, about 707.7% upside from the current price of $1.30. Coverage is limited, so the data is for reference only. Data as of Sep 8, 2026; this does not constitute investment advice.
Sep 8, 2026Price forecast
$10.50707.69%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 7, 2026
Forecast met0.0%
Stock price$1.30
Avg. target$13.8
High target$20
Low target$8
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.